Who’s ever heard of ivabradine? Who even knows how to pronounce it?

In a nutshell it’s a newish negatively chronotropic drug used to manage stable angina in patients who don’t tolerate ß blockers. I certainly had never heard of it until a leaflet was handed to me by a smiling drug company representative at a sponsored lunch before a hospital grand round.

I know it’s not politically correct to say this, but I quite enjoy a free lunch, especially when it comes from Marks & Spencer. Judging by the number …